UAE – The Department of Health – Abu Dhabi (DoH) has signed a declaration of collaboration with global biopharmaceutical company, MSD GCC.
According to state news agency WAM, the agreement between the entities was signed at the BIO International Convention in San Diego, US.
Abdulla bin Mohammed Al Hamed, chairman of the DoH, led the delegation, which is visiting the US this month to expand and explore prospects of joint collaboration in the healthcare sector.
The Abu Dhabi delegation to the US witnessed the participation of ten key entities in the life science ecosystem in Abu Dhabi including the Department of Health – Abu Dhabi (DoH), Abu Dhabi Investment Office (ADIO), Mubadala Health, G42 Healthcare, Abu Dhabi Ports, ADQ, Etihad Cargo, Khalifa University, Hayat-vax and Pure Health.
The initiatives planned in the declaration of collaboration are aligned with the DoH’s Abu Dhabi Healthcare Strategic Plan, and its mission to promote the Emirate of Abu Dhabi as a leading global life science and health technology hub.
The first area for collaboration will look at scientific research and identifying ways to improve public health, with an emphasis on the use of real-world evidence to address local health needs and improve outcomes.
Dr. Asma Al Mannaei, Executive Director, Research Centre and Innovation, at the DoH said, “Abu Dhabi is continuously expanding collaborations with global partners to bring innovative treatments and breakthrough solutions to the UAE and the region.
“Scientific research creates a strong foundation upon which we can strengthen our population health. The research will help us inform policies and programmes as well as boost our clinical research readiness level,” Al Mannaei added.
The second area will include continuing medical education programmes for healthcare professionals and promoting patient and public healthcare education through teaching programmes and awareness campaigns.
Collaborating to foster educational and capability-building partnerships aims to ensure the provision of advanced medical education to support the ongoing highest standards of care.
This will include continued medical education programs for healthcare professionals, as well as promoting patient and public healthcare education through teaching programs and awareness campaigns.
The third area for collaboration will focus on increasing the use of innovative technological and digital health solutions to provide the highest quality care outcome.
Activities include exploring the use of digital technology, artificial intelligence and innovative for precision and personalized medicine to improve diagnosis and optimize the delivery of care.
The initiatives planned in the declaration of collaboration are aligned with the DoH’s Abu Dhabi Healthcare Strategic Plan, and its mission to promote the Emirate of Abu Dhabi as a leading global life science and health technology hub.
Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE
